SCHEMBL11904599

SCHEMBL11904599

CCCCCc1nc2cc(OC(F)(F)F)ccc2[nH]1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.47
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC10 Q969S8 1/20 0.46
HDAC11 Q96DB2 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
HDAC9 Q9UKV0 1/20 0.46
HDAC5 Q9UQL6 1/20 0.46
POLB P06746 1/20 0.43
ALDH1A1 P00352 1/20 0.40
KMT2A Q03164 2/20 0.40
TRPV1 Q8NER1 1/20 0.39
MAPT P10636 2/20 0.39
PKM P14618 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11903503 0.91 PDE10A (0.50) PDE10AHDAC3HDAC4HDAC1HDAC7
SCHEMBL11904604 0.90 PDE10A (0.58) PDE10AKMT2ATRPV1MAPTPKM
SCHEMBL10284435 0.85 DDAH1 (0.49) PDE10AKMT2ATRPV1KDM4E
SCHEMBL10436144 0.84 CYP1A2 (0.49) POLBALDH1A1KMT2A
SCHEMBL25987878 0.83 PDE10A (0.50) PDE10AHDAC3HDAC4HDAC1HDAC7
SCHEMBL11903504 0.80 PDE10A (0.62) PDE10APOLBKMT2ATRPV1KDM4E
SCHEMBL23389133 0.80 PDE10A (0.46) PDE10AHDAC1HDAC2KMT2ATRPV1
SCHEMBL11903491 0.80 RHEB (0.50) PDE10AHDAC3HDAC4HDAC1HDAC7
SCHEMBL9194507 0.80 CYP1A2 (0.48) POLBALDH1A1KMT2A
SCHEMBL16189003 0.79 PKM (0.51) PDE10AKMT2ATRPV1MAPTPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8293780-B1 Anti-cancer agents based on 6-trifluoromethoxybenzimidazole derivatives and method of making U.S. DEPARTMENT OF ENERGY (US) 2012-10-23 US disclosed
US-8242284-B1 Anti-cancer agents based on 6-trifluoromethoxybenzimidazole derivatives and method of making THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) 2012-08-14 US disclosed